ERIC I RICHMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ERIC I RICHMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERIC I RICHMAN. ERIC I RICHMAN is Director in NeuBase Therapeutics, Inc. ($OHRP) and Director in PHARMATHENE, INC ($PIP) and Director in ADMA BIOLOGICS, INC. ($ADMA).
Latest Insider Trading Transactions of ERIC I RICHMAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADMA, ALT, NBSE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 2021 | NBSE | NeuBase Therapeuti ... | RICHMAN ERIC I | Director | Buy | P | 5.00 | 5,000 | 25,000 | 41,080 | 36.1 K to 41.1 K (+13.86 %) |
| Sep 11 2020 | OHRP | NeuBase Therapeuti ... | RICHMAN ERIC I | Director | Option Exercise | A | 8.80 | 14,634 | 128,779 | 14,634 | |
| May 04 2020 | OHRP | NeuBase Therapeuti ... | RICHMAN ERIC I | Director | Buy | P | 6.00 | 8,333 | 49,998 | 36,080 | 27.7 K to 36.1 K (+30.03 %) |
| May 04 2020 | OHRP | NeuBase Therapeuti ... | RICHMAN ERIC I | Director | Buy | P | 6.00 | 2,500 | 15,000 | 27,747 | 25.2 K to 27.7 K (+9.90 %) |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | A | 2.92 | 15,000 | 43,725 | 15,000 | |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Grant | A | 0.00 | 7,500 | 0 | 44,030 | 36.5 K to 44 K (+20.53 %) |
| Jul 16 2019 | OHRP | NeuBase Therapeuti ... | RICHMAN ERIC I | Director | Option Exercise | A | 5.39 | 227,330 | 1,225,309 | 227,330 | |
| Jul 16 2019 | OHRP | NeuBase Therapeuti ... | RICHMAN ERIC I | Director | Option Exercise | A | 5.39 | 227,330 | 1,225,309 | 227,330 | |
| Jul 16 2019 | OHRP | NeuBase Therapeuti ... | RICHMAN ERIC I | Director | Grant | A | 0.00 | 25,247 | 0 | 25,247 | 0 to 25.2 K |
| Jul 16 2019 | OHRP | NeuBase Therapeuti ... | RICHMAN ERIC I | Director | Grant | A | 0.00 | 25,247 | 0 | 25,247 | 0 to 25.2 K |
| Mar 15 2019 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | A | 3.89 | 30,000 | 116,700 | 30,000 | |
| Jun 25 2018 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | A | 4.91 | 17,500 | 85,925 | 17,500 | |
| Jun 11 2018 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Buy | P | 4.78 | 5,230 | 24,999 | 36,530 | 31.3 K to 36.5 K (+16.71 %) |
| Nov 13 2017 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Buy | P | 2.15 | 25,000 | 53,750 | 31,300 | 6.3 K to 31.3 K (+396.83 %) |
| Jul 17 2017 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | M | 2.68 | 2,800 | 7,504 | 0 | |
| Jul 17 2017 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Buy | M | 2.68 | 2,800 | 7,504 | 6,300 | 3.5 K to 6.3 K (+80.00 %) |
| Jun 08 2017 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | A | 3.66 | 78,144 | 286,007 | 78,144 | |
| Feb 16 2017 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 2.20 | 20,000 | 44,000 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.69 | 20,000 | 33,800 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.71 | 135,660 | 231,979 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.94 | 240,000 | 465,600 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.19 | 37,500 | 44,625 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 2.46 | 30,573 | 75,210 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 2.20 | 20,000 | 44,000 | 898,055 | 878.1 K to 898.1 K (+2.28 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.69 | 20,000 | 33,800 | 878,055 | 858.1 K to 878.1 K (+2.33 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.71 | 135,660 | 231,979 | 858,055 | 722.4 K to 858.1 K (+18.78 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.94 | 240,000 | 465,600 | 722,395 | 482.4 K to 722.4 K (+49.75 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.19 | 37,500 | 44,625 | 482,395 | 444.9 K to 482.4 K (+8.43 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 2.46 | 30,573 | 75,210 | 444,895 | 414.3 K to 444.9 K (+7.38 %) |
| Sep 30 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.19 | 37,500 | 44,625 | 37,500 | |
| Sep 30 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.48 | 100,000 | 148,000 | 0 | |
| Sep 30 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.51 | 100,000 | 151,000 | 0 | |
| Sep 30 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.19 | 37,500 | 44,625 | 414,322 | 376.8 K to 414.3 K (+9.95 %) |
| Sep 30 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.48 | 100,000 | 148,000 | 376,822 | 276.8 K to 376.8 K (+36.12 %) |
| Sep 30 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.51 | 100,000 | 151,000 | 276,822 | 176.8 K to 276.8 K (+56.55 %) |
| Jun 03 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
| Apr 15 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.19 | 75,000 | 89,250 | 75,000 | |
| Apr 15 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.16 | 91,121 | 105,700 | 0 | |
| Apr 15 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.16 | 150,000 | 174,000 | 0 | |
| Apr 15 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.76 | 13,233 | 23,290 | 0 | |
| Apr 15 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Sell | S | 2.20 | 75,000 | 165,000 | 176,822 | 251.8 K to 176.8 K (-29.78 %) |
| Apr 15 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.19 | 75,000 | 89,250 | 251,822 | 176.8 K to 251.8 K (+42.42 %) |
| Apr 15 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Sell | S | 2.20 | 91,121 | 200,466 | 176,822 | 267.9 K to 176.8 K (-34.01 %) |
| Apr 15 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.16 | 91,121 | 105,700 | 267,943 | 176.8 K to 267.9 K (+51.53 %) |
| Apr 15 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Sell | S | 2.20 | 150,000 | 330,000 | 176,822 | 326.8 K to 176.8 K (-45.90 %) |
| Apr 15 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.16 | 150,000 | 174,000 | 326,822 | 176.8 K to 326.8 K (+84.83 %) |
| Apr 15 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Sell | S | 2.20 | 13,233 | 29,113 | 176,822 | 190.1 K to 176.8 K (-6.96 %) |
| Apr 15 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.76 | 13,233 | 23,290 | 190,055 | 176.8 K to 190.1 K (+7.48 %) |
| Apr 11 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.76 | 6,400 | 11,264 | 13,233 | |
| Apr 11 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | M | 1.76 | 5,367 | 9,446 | 19,633 | |
| Apr 11 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Sell | S | 2.20 | 6,400 | 14,080 | 176,822 | 183.2 K to 176.8 K (-3.49 %) |
| Apr 11 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.76 | 6,400 | 11,264 | 183,222 | 176.8 K to 183.2 K (+3.62 %) |
| Apr 11 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Sell | S | 2.20 | 5,367 | 11,807 | 176,822 | 182.2 K to 176.8 K (-2.95 %) |
| Apr 11 2016 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Buy | M | 1.76 | 5,367 | 9,446 | 182,189 | 176.8 K to 182.2 K (+3.04 %) |
| Feb 01 2016 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | A | 5.96 | 9,000 | 53,640 | 9,000 | |
| Aug 04 2015 | PIP | PHARMATHENE, INC | RICHMAN ERIC I | Director | Option Exercise | A | 1.69 | 20,000 | 33,800 | 20,000 | |
| Mar 17 2015 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Buy | P | 7.82 | 1,000 | 7,820 | 3,500 | 2.5 K to 3.5 K (+40.00 %) |
| Mar 17 2015 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Buy | P | 7.90 | 2,500 | 19,750 | 2,500 | 0 to 2.5 K |
Page: 1